Autobio Diagnostics Co

Autobio Diagnostics Co Dividend Yield

The Dividend Yield of Autobio Diagnostics Co (603658.SS) as of Oct 20, 2026 is 3.52 %. In the previous year, Dividend Yield was 2.94 % — a change of 19.76% (higher).

Dividend Yield

3.52 %

YoY

19.76%

Last updated:

Dividend Yield of Autobio Diagnostics Co is 2025 3.52 % . Dividend Yield of Autobio Diagnostics Co was 2024 2.94 % . It decreases by 19.76% higher compared to the previous year.

The Autobio Diagnostics Co Dividend Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Yield
Date
Dividend Yield
Jan 1, 2018
1.55 CNY
Jan 1, 2019
1.72 CNY
Jan 1, 2020
1.93 CNY
Jan 1, 2021
1.82 CNY
Jan 1, 2022
2.01 CNY
Jan 1, 2023
2.23 CNY
Jan 1, 2024
2.94 CNY
Jan 1, 2025
3.52 CNY
The Autobio Diagnostics Co Dividend Yield history
YEARDividend YieldYoY
3.52 %+19.76%
2.94 %+31.51%
2.23 %+11.11%
2.01 %+10.12%
1.82 %-5.55%
1.93 %+12.50%
1.72 %+11.12%
1.55 %-28.72%
2.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co., Ltd. generates revenue through the sale of in vitro diagnostic reagents and instruments, including gnostic products, microbiology detection products, and related devices. The company's immunodiagnostic products consist of microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. Microbiology detection products feature training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers, all distributed within domestic markets. The firm targets domestic healthcare providers and laboratories as primary buyers of its diagnostic reagents and instruments. Its core products serve clinical diagnostics needs for infectious disease testing, microbial identification, and immune response analysis. The company's product portfolio emphasizes domestic market distribution, with no mention of international sales channels or export activities. Autobio Diagnostics' revenue streams are derived from the manufacturing and distribution of diagnostic reagents, instruments, and related devices. The company focuses on domestic market penetration through its product range, which includes specialized reagents for microbiology and immunodiagnosis. No additional revenue sources such as service contracts or software licensing are indicated in the business description. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Dividend Yield of Autobio Diagnostics Co is 3.52 % in 2025.

Dividend Yield of Autobio Diagnostics Co changed from 2.94 % to 3.52 %, representing a 19.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Yield Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Autobio Diagnostics Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Autobio Diagnostics Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Autobio Diagnostics Co